Methyl 2-[(2R,3S,4R)-4-hydroxy-5-methylidene-2-octyloxolan-3-yl]prop-2-enoate
C17H28O4 — CID 122606321
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[(2R,3S,4R)-4-hydroxy-5-methylidene-2-octyloxolan-3-yl]prop-2-enoate
Methyl 2-[(2R,3S,4R)-4-hydroxy-5-methylidene-2-octyloxolan-3-yl]prop-2-enoate (PubChem CID 122606321) has the molecular formula C17H28O4 and a molecular weight of 296.41 g/mol. Its IUPAC name is methyl 2-[(2R,3S,4R)-4-hydroxy-5-methylidene-2-octyloxolan-3-yl]prop-2-enoate.
Molecular Properties
| Compound Name | Methyl 2-[(2R,3S,4R)-4-hydroxy-5-methylidene-2-octyloxolan-3-yl]prop-2-enoate |
|---|---|
| PubChem CID | 122606321 |
| Molecular Formula | C17H28O4 |
| Molecular Weight | 296.41 g/mol |
| Exact Mass | 296.20 |
| IUPAC Name | methyl 2-[(2R,3S,4R)-4-hydroxy-5-methylidene-2-octyloxolan-3-yl]prop-2-enoate |
| SMILES | C=C(C(=O)OC)[C@@H]1[C@@H](CCCCCCCC)OC(=C)[C@@H]1O |
| InChI | InChI=1S/C17H28O4/c1-5-6-7-8-9-10-11-14-15(12(2)17(19)20-4)16(18)13(3)21-14/h14-16,18H,2-3,5-11H2,1,4H3/t14-,15-,16+/m1/s1 |
| InChIKey | HQOQWMPMOSXQOJ-OAGGEKHMSA-N |
| XLogP | 3.36 |
| TPSA | 55.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 296.41 |
| LogP ≤ 5 | 3.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122606321 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.